Assessing the Effects of Supplementary Alfacalcidol Intake on Peroxisome Proliferator-activated Receptor-coactivator-1-aspha Vitamin D Receptor and Peroxisome Proliferator-activated Receptor Gamma Gene Expression in Obese Subjects
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alfacalcidol (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 18 Jan 2013 New trial record
- 27 Dec 2012 Biomarkers information updated